Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.

Farrar JT, Bilker WB, Cochetti PT, Argoff CE, Haythornthwaite J, Katz NP, Gilron I

Open source

DOI
10.1097/j.pain.0000000000002331
Published
2022 Jan 1
Container
Pain
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/j.pain.0000000000002331,
  title = {Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.},
  author = {Farrar JT and Bilker WB and Cochetti PT and Argoff CE and Haythornthwaite J and Katz NP and Gilron I},
  year = {2022},
  journal = {Pain},
  doi = {10.1097/j.pain.0000000000002331},
  url = {https://doi.org/10.1097/j.pain.0000000000002331}
}

RIS

TY  - JOUR
TI  - Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.
AU  - Farrar JT
AU  - Bilker WB
AU  - Cochetti PT
AU  - Argoff CE
AU  - Haythornthwaite J
AU  - Katz NP
AU  - Gilron I
PY  - 2022
JO  - Pain
DO  - 10.1097/j.pain.0000000000002331
UR  - https://doi.org/10.1097/j.pain.0000000000002331
ER  - 

APA

JT, F., WB, B., PT, C., CE, A., J, H., NP, K., & I, G. (2022). Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.. Pain. https://doi.org/10.1097/j.pain.0000000000002331

Source records